|
Nov 28
|
Bayer Sees No Quick Fixes After Bankers Game Out Breakup
|
|
Nov 26
|
Bayer chief blames thin drug pipeline on ‘years of under-investment’
|
|
Nov 25
|
Bayer CEO Says Breakup Wouldn’t Fix All of the Company’s Ills
|
|
Nov 24
|
Bayer’s Outlook Lowered by Moody’s on ‘Credit Negative Events’
|
|
Nov 24
|
Morning Brew: iRobot Surges on Amazon Deal Approval, Tesla Eyes India Factory
|
|
Nov 13
|
Bayer Pulling Lymphoma Drug Aliqopa From U.S.
|
|
Nov 10
|
U.S. Stocks Are Relatively Pricey. Here Are 3 Bargains From Europe.
|
|
Nov 8
|
Health Care Roundup: Market Talk
|
|
Nov 8
|
Bayer's (BAYRY) Q3 Earnings and Revenues Miss Estimates
|
|
Nov 8
|
Bayer’s CEO Weighs Breakup in U-Turn for German Conglomerate
|
|
Nov 8
|
Bayer’s new CEO signals business shake-up, plans to slash management
|
|
Nov 8
|
Bayer Weighs Structural Changes But Rules Out Three-Way Split
|
|
Nov 8
|
Bayer chief blasts conglomerate’s performance as ‘unacceptable’
|
|
Nov 8
|
Bayer CEO Serious About Structural Overhaul
|
|
Nov 8
|
UPDATE 4-Bayer weighs break-up options as management job cuts loom
|
|
Nov 8
|
Bayer weighs break-up options as management job cuts loom
|
|
Nov 7
|
UPDATE 2-Appeals court blocks California warning labels for glyphosate weedkillers
|
|
Nov 7
|
Appeals court blocks California warning requirement for glyphosate
|
|
Nov 3
|
California jury awards $332 million to man who blamed his cancer on use of Monsanto weedkiller
|
|
Nov 2
|
Regeneron (REGN) Q3 Earnings & Sales Top, Eylea Sales Decline
|